π π©ββοΈ Scientists from our institution and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.
#AstraZeneca #DiabetesResearch #PharmaceuticalScience
Read more: https://go.epfl.ch/A1U-en
